micro glp-1 medications have transformed the way we approach medical weight loss. For many patients, a micro-dosing strategy offers a more gradual, highly personalized approach — supporting steady fat loss Microdosing Tirzepatide and Semaglutide for

Muscle Mass and Body Composition Research in growth hormone-deficient and intact animal models showed effects on lean body mass: 15.3% increase in body weight in GH-deficient mice treated with ipamorelin over 9 weeks Enhanced protein synthesis and nitrogen retention in skeletal muscle tissue Dose-dependent effects on body weight gain and lean mass accretion Preserved muscle mass during catabolic conditions in experimental models Studies using DEXA scanning confirmed increases in lean tissue mass with corresponding reductions in fat mass percentage

Maybe it feels like a band-aid instead of a real solution

Alvin Li is an employee of CorEvitas, LLC, and a stockholder of Eli Lilly

Quick reference conversion tables by dose Sometimes you just need a fast answer